An amazing dental success story


The biotech Wishbone has developed a novel product based on Belgian cattle bones that increases the success rate of bone grafts in dental surgery.

Founded in 2013 by Eric Rompen, France Lambert and Geoffrey Lecloux, three dental specialists from the University of Liège, Wishbone has developed technology over the past few years that allows faster bone regeneration when dental implant grafting has to be considered.

This Belgian company based in Flémalle (Liège province), has developed a process used in the manufacture of a xenograft material, i.e. a bone substitute of animal origin that can be used in dental reconstruction surgery. Because when dental implants are required, it is important to ensure that the jawbone forms a solid foundation. However, tooth loss is very often associated with a weakening of these bones.

Thanks to a biomaterial extracted from the mineral part of cattle bones, Belgian researchers are able to guarantee faster and safer bone regeneration than that obtained using products currently on the market.

Before marketing this innovative (and amazing) technology on our continent, the Liège-based company still has to wait until the end of the year for European authorisation. But on the other side of the Atlantic, Wishbone can rely on a vast network of surgeons to begin the first treatments, as the U.S. Food and Drug Administration (FDA) has already given the green light.

Americans will be the first to get a bright smile thanks to Belgian cattle bones. There is no doubt that other dentists around the world will use this technique.